Healthpeak Properties, Inc. (NYSE:DOC) Receives Average Rating of “Moderate Buy” from Analysts

Healthpeak Properties, Inc. (NYSE:DOC) has been given an average recommendation of “Moderate Buy” by the sixteen ratings firms that are currently covering the stock, Marketbeat reports. Five analysts have rated the stock with a hold recommendation, ten have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $22.93.

Several analysts have commented on the stock. Mizuho dropped their target price on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a report on Thursday, December 5th. StockNews.com cut shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a research report on Wednesday, October 30th. Royal Bank of Canada increased their price objective on shares of Healthpeak Properties from $25.00 to $26.00 and gave the stock an “outperform” rating in a research report on Monday, November 4th. Robert W. Baird boosted their target price on shares of Healthpeak Properties from $24.00 to $25.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th. Finally, Citigroup boosted their price target on shares of Healthpeak Properties from $20.00 to $22.00 and gave the company a “neutral” rating in a research note on Thursday, August 22nd.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in DOC. State Street Corp acquired a new stake in shares of Healthpeak Properties during the 3rd quarter worth approximately $1,093,576,000. Geode Capital Management LLC acquired a new position in shares of Healthpeak Properties during the 3rd quarter worth about $403,898,000. Charles Schwab Investment Management Inc. purchased a new stake in shares of Healthpeak Properties during the 3rd quarter worth approximately $230,988,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new position in shares of Healthpeak Properties during the third quarter worth about $175,697,000. Finally, Sumitomo Mitsui Trust Group Inc. acquired a new position in shares of Healthpeak Properties in the 3rd quarter valued at $102,615,000. 93.57% of the stock is owned by institutional investors and hedge funds.

Healthpeak Properties Stock Performance

NYSE:DOC opened at $19.98 on Thursday. The company has a current ratio of 1.31, a quick ratio of 1.31 and a debt-to-equity ratio of 0.93. The firm’s fifty day simple moving average is $21.90 and its 200 day simple moving average is $21.40. The firm has a market capitalization of $13.97 billion, a PE ratio of 42.51, a PEG ratio of 2.37 and a beta of 1.13. Healthpeak Properties has a 1 year low of $16.01 and a 1 year high of $23.26.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings results on Thursday, October 24th. The real estate investment trust reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.44 by ($0.32). The company had revenue of $700.40 million for the quarter, compared to analyst estimates of $682.51 million. Healthpeak Properties had a return on equity of 3.53% and a net margin of 12.10%. The firm’s quarterly revenue was up 25.9% on a year-over-year basis. During the same quarter last year, the company earned $0.45 EPS. On average, sell-side analysts anticipate that Healthpeak Properties will post 1.8 EPS for the current year.

Healthpeak Properties Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Monday, November 4th were paid a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 6.01%. The ex-dividend date of this dividend was Monday, November 4th. Healthpeak Properties’s dividend payout ratio is currently 255.32%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.